The largest database of trusted experimental protocols

6 protocols using anti cd49d pe

1

Multiparameter FACS Analysis of Activated T-cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For FACS analysis HUVEC were incubated with anti-HLA-DR PE conjugated antibody (BD-Biosciences, Heidelberg, Germany). Anti-CD3/anti-CD28 activated T-cells four color-staining was performed using the following monoclonal antibodies: anti-CD49d-PE, anti-CD29-APC, anti-CD11a-BV421 and anti-CD18-FITC (all purchased from BD Biosciences, Heidelberg, Germany). For each antibody optimal dilutions were assessed by serial dilutions. Stained samples were measured on a BD FACSlyricTM Flow cytometer using both negative and fluorescence-minus-one controls. Compensation was performed with BD compBeads (BD Biosciences, Heidelberg, Germany). Data analysis was performed using FlowJo software version 5.2 (FlowJo LLC, Ashland, USA).
+ Open protocol
+ Expand
2

CLL B Cell Surface Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated CLL B cells were cultured with and without MSCs and treated with 5μM kinase inhibitors as above described. Cells (5×105 for each assay) were collected after 48h, leaving intact the adherent layer, and stained with anti-CD49d PE (BD Biosciences), anti-CCR7 FITC (R&D Systems Inc., Minneapolis, MN, USA), anti-CXCR4 PE (R&D Systems Inc.) anti-CXCR3 PE-Cy5.5 (BD Biosciences, Franklin Lakes, NJ, USA), anti-CXCR5 FITC (R&D Systems Inc.), and anti-CD19 APC (BD Biosciences) monoclonal antibodies. Cells were washed with PBS1X and incubated with saturating concentrations of the appropriate antibodies for 15 minutes at room temperature. 20,000 total events were acquired using FACSCanto A (Becton Dickinson) and the data were analysed by FACSDiva 7 software. Samples were gated on intact cells by forward scatter (FSC) vs side scatter (SSC). For analysis, a second gating step on CD19+ cells was used. Here, we used a difference between the Mean Fluorescence Intensity (MFI) of fully-stained samples and the Fluorescence Minus One (FMO) controls.
+ Open protocol
+ Expand
3

Immunophenotypic Analysis of Hematopoietic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh leukapheresis products were stained with the following monoclonal antibodies (MoAbs): anti-CXCR4–PE, anti-CD49d–PE, anti-CD11a–PE, anti-CD34–FITC (BD Biosciences, Franklin Lakes, NJ) or corresponding isotype controls. Additionally, PB mononuclear cells (PBMNCs) were isolated by density gradient centrifugation, viably frozen, and stored in liquid nitrogen until use. Thawed PBMNCs were stained with anti-CD34–FITC (BD Biosciences), CD44–FITC, anti-CD38–PE, anti-CD34–PE (Beckman Coulter), and anti-CD133–APC MoAbs (Miltenyi Biotec, Bergisch-Gladbach, Germany). The percentage of cells expressing respective receptors and mean fluorescence intensity values in relation to isotype controls (MFIRs) were analyzed with a flow cytometer and its accompanying software (Gallios and Caluza, respectively, both Beckman Coulter).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of Liver Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric analysis was performed on CytoFLEX (Beckman Coulter, CA, USA). To analyze liver infiltrating cells, hematopoietic cells were isolated by MACS Liver dissociation kit (Miltnyi Biotec Inc.) and Gentle MACS (Miltnyi Biotec Inc.). Antibodies were sourced from Biolegend: anti-CD3 phycoerythrin/Cyanine7 (PE/Cy7; 17A2), anti-CD4 phycoerythrin (PE; GK1.5), anti-B220 PE (RA3-6B2), anti-CD90.2 PE (30-H12), anti-CD11c PE/Cy7 (N418), anti-F4/80 fluorescein isothiocyanate (FITC; BM8), anti-NK1.1 Alexa Fluor 488 (PK136), anti-CD49b PE (DX5), anti-CD44 allophycocyanin (APC; IM7), anti-CD62L allophycocyanin/Cyanine7 (APC/Cy7 (MEL-14), anti-CD25 PE (PC61.5), anti-CD69 FITC (H1.2F3), anti-CD49d PE (MFR4.B), anti-CXCR3 APC (CXCR3-173), anti-PD-1 PE (29F.1A12), anti-KLRG-1 APC (2F1/KLRG1), anti-LFA-1 PE (H155-78), anti-LPAM-1 PE (DATK32), anti-H-2 Kb APC (AF6-88.5) and anti-CD8a FITC (53–6.7), anti-CD11b PE (M1/70) from BD Biosciences.
+ Open protocol
+ Expand
5

Flow Cytometric Analysis of Immune Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated as mentioned above. After incubation staining for fluorescence-activating cell sorting (FACS) followed. 5 × 105 cells/tube were incubated with 10 µl anti-CD49d PE (purchased from BD Biosciences Europe, Erembodegem, Belgium), CD102 PE (purchased from BD Biosciences Europe, Erembodegem, Belgium) or CXCR4 PE (purchased from Beckman Coulter GmbH, Krefeld, Germany) and 10 µl anti-mouse IgG1, κ PE for 30 min at 18–22°C in the dark. When examined the next day, cells were fixed in 250 µl FACS-Buffer and 250 µl 2% formaldehyde and then analyzed by flow cytometry.
+ Open protocol
+ Expand
6

Characterization of CXCR4 and CXCR7 Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic human CXCL12 (SDF1α) was purchased from R&D Systems (Minneapolis, MN, USA). The small molecule CXCR4 inhibitor, plerixafor, was purchased from SIGMA (St. Louis, MO, USA), and BKT140, a peptide CXCR4 inhibitor, was provided by Dr. Peled (Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel). Dexamethasone and vincristine sulfate were purchased from SIGMA (St. Louis, MO, USA) and 4-Hydroperoxy cyclophosphamide was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Anti-CXCR4-phycoerythrin (PE) antibodies (12G5 clone) were purchased from BD Pharmingen (San Jose, CA, USA) and anti-CXCR4-allophycocyanin (APC) antibodies (12G5 clone) were purchased from eBioscience (San Diego, CA, USA). Anti-human/mouse-CXCR7-PE antibodies (clone 8F11-M16) were purchased from Biolegend (San Diego, CA). All other antibodies and isotype controls (anti-CD44- FITC, anti-CD54-PE, anti-CXCR5-PE, anti-CXCR3-PE, anti-CD62L-FITC, anti-CD49D-PE and CCR7-PE) and respective isotype controls were purchased from BD Pharmingen.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!